Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
New York Law Overhauls Ailing EMS Services
Public Policy New York Law Overhauls Ailing EMS Services

A groundbreaking legislative mandate is set to fundamentally reshape the landscape of emergency medical response across New York, compelling a system-wide reevaluation of services long strained by critical resource and personnel shortages. For years, communities have grappled with a patchwork

Why Is Ghana Banning Alcoholic Energy Drinks?
Public Policy Why Is Ghana Banning Alcoholic Energy Drinks?

The once-ubiquitous sight of brightly colored cans promising both an energetic lift and an alcoholic buzz has officially disappeared from Ghanaian store shelves, marking a significant regulatory shift that redefines the nation's beverage industry. This decisive action, which culminated in the

Jersey to Overhaul Digital Health After Failing Grade
Public Policy Jersey to Overhaul Digital Health After Failing Grade

A score of zero is rarely a catalyst for celebration, yet for Jersey's healthcare system, it marked the painful but necessary beginning of a complete digital reinvention. The island has embarked on an ambitious and costly journey to rebuild its technological foundations from the ground up,

AI Medical Scribes – Review
Public Policy AI Medical Scribes – Review

The crushing weight of administrative tasks has long overshadowed the core mission of healthcare, but the advent of intelligent automation is finally offering physicians a reprieve from their keyboards. The emergence of AI Medical Scribes represents a significant advancement in the healthcare

FDA Clears Ascletis Oral GLP-1 for Phase II Diabetes Trial
Public Policy FDA Clears Ascletis Oral GLP-1 for Phase II Diabetes Trial

A New Contender Enters the Ring: Ascletis Gains Key FDA Nod for Oral Diabetes Drug Ascletis Pharma has secured a critical milestone in the competitive metabolic disease landscape, receiving Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This approval

Why Can't the FDA Confirm Your Cosmetics Are Safe?
Public Policy Why Can't the FDA Confirm Your Cosmetics Are Safe?

The daily ritual of applying makeup and skincare products is built on an implicit trust that these items are safe, yet recent government findings reveal a significant gap between consumer confidence and regulatory certainty. A new report from the Food and Drug Administration (FDA) has cast a

Why Tech Fails Mental Health Without Clinicians
Public Policy Why Tech Fails Mental Health Without Clinicians

While venture capital pours into digital mental health platforms promising to solve a global crisis, a quieter, more devastating crisis is unfolding within the profession itself, one that technology consistently fails to address. The promise of an accessible, tech-driven future for mental

New Oregon Laws Target Medical Debt, Squatters, and AI
Public Policy New Oregon Laws Target Medical Debt, Squatters, and AI

Oregon's 2026 Legislative Overhaul a New Era of Protection for Residents The legal ground beneath Oregonians' feet has decisively shifted with the arrival of nearly 300 new laws, a direct result of the ambitious and wide-ranging 2025 legislative session. As of January 1, these statutes

FDA Approves 5-Minute Injection for Lung Cancer
Public Policy FDA Approves 5-Minute Injection for Lung Cancer

The landscape of oncology care has been profoundly altered by an approval that transforms a multi-hour intravenous commitment into a brief, five-minute subcutaneous injection for certain lung cancer patients. The U.S. Food and Drug Administration (FDA) has given its consent to RYBREVANT FASPRO™, a n

Senate Fails to Prevent ACA Premium Hikes for Millions
Public Policy Senate Fails to Prevent ACA Premium Hikes for Millions

The financial stability of millions of American households now hangs precariously in the balance following a congressional stalemate that promises to trigger a severe healthcare affordability crisis. Without legislative intervention, a critical support system that has made health insurance

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later